Preempting autoimmune disease with induced antigen tolerance
Kathryn Dupnik
Division of Infectious Diseases, Center for Global Health, Weill Medical College of Cornell University, New York, NY 10065, USA. Email: kad9040{at}med.cornell.edu
See allHide authors and affiliations
Science Translational Medicine 22 Mar 2017: Vol. 9, Issue 382, eaan0764 DOI: 10.1126/scitranslmed.aan0764
Kathryn Dupnik
Division of Infectious Diseases, Center for Global Health, Weill Medical College of Cornell University, New York, NY 10065, USA. Email:
Division of Infectious Diseases, Center for Global Health, Weill Medical College of Cornell University, New York, NY 10065, USA. Email: kad9040{at}med.cornell.edu
Preempting autoimmune disease with induced antigen tolerance
By Kathryn Dupnik
Science Translational Medicine
Transfusion of red blood cells with antigenic peptides added to surface proteins is being explored as a tolerance-inducing intervention for autoimmune disease.
Preempting autoimmune disease with induced antigen tolerance
By Kathryn Dupnik
Science Translational Medicine
Transfusion of red blood cells with antigenic peptides added to surface proteins is being explored as a tolerance-inducing intervention for autoimmune disease.